Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12‐Week, Randomized, Controlled Study
Kirsten Müller‐Vahl, Carolin Fremer, Chan Beals, et al.
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2413-2418
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 91
European clinical guidelines for Tourette syndrome and other tic disorders: summary statement
Kirsten Müller‐Vahl, Natalia Szejko, Cara Verdellen, et al.
European Child & Adolescent Psychiatry (2021) Vol. 31, Iss. 3, pp. 377-382
Open Access | Times Cited: 68
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases
Chu Chen
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108394-108394
Open Access | Times Cited: 28
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders – Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study
Kirsten Müller‐Vahl, Anna Pisarenko, Natalia Szejko, et al.
Psychiatry Research (2023) Vol. 323, pp. 115135-115135
Open Access | Times Cited: 18
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
Ming Jiang, Mirjam Huizenga, Jonah L. Wirt, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature
Kirsten Müller‐Vahl
Pharmacopsychiatry (2024) Vol. 57, Iss. 03, pp. 104-114
Open Access | Times Cited: 8
Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature
Jessica Frey, Irene A. Malaty
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 2, pp. 123-142
Open Access | Times Cited: 26
Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome
Natalia Szejko, Kamila Saramak, Adam Lombroso, et al.
Neurologia i Neurochirurgia Polska (2021) Vol. 56, Iss. 1, pp. 28-38
Open Access | Times Cited: 28
Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
Saar Anis, Corinne Zalomek, Amos D. Korczyn, et al.
Behavioural Neurology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 20
Placebo and Nocebo Responses in Pharmacological Trials of Tic Disorders: A Meta‐Analysis
Simeng Wang, Zhiyi Xiong, Yuehua Cui, et al.
Movement Disorders (2024) Vol. 39, Iss. 3, pp. 585-595
Open Access | Times Cited: 4
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27
A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome
Elia Abi‐Jaoude, Tracy Bhikram, Ferdous Parveen, et al.
Cannabis and Cannabinoid Research (2022) Vol. 8, Iss. 5, pp. 835-845
Closed Access | Times Cited: 17
Radiosynthesis and Evaluation of Novel 18F Labeled PET Ligands for Imaging Monoacylglycerol Lipase
Yinlong Li, Wakana Mori, Ahmad Chaudhary, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117246-117246
Closed Access
Premonitory urge in tic disorders – a scoping review
John B. Wohlgemuth, Kelly H. Watson, Kenneth J. Gill, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Enhancement of the endocannabinoid system through monoacylglycerol lipase inhibition relieves migraine-associated pain in mice
Elizaveta Mangutov, Yaseen Awad-Igbaria, Kendra Siegersma, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Chronic intermittent ethanol produces nociception through endocannabinoid-independent mechanisms in mice
Cristina Miliano, Yanbin Dong, M Proffit, et al.
Neuropharmacology (2025), pp. 110502-110502
Closed Access
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms
Abhishek Lenka, Joseph Jankovic
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 10, pp. 1025-1033
Closed Access | Times Cited: 3
Structure-Guided Discovery of cis-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors
Bernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study
Kirsten Müller‐Vahl, Carolin Fremer, Chan Beals, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 03, pp. 148-156
Open Access | Times Cited: 20
Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams–Beuren syndrome
Alba Navarro-Romero, Lorena Galera-López, Paula Ortiz‐Romero, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 14
Binding of the monoacylglycerol lipase (MAGL) radiotracer [3H]T-401 in the rat brain after status epilepticus
Jens D. Mikkelsen, Sanjay S. Aripaka, Cansu Bilister Eğilmez, et al.
Neurochemistry International (2024) Vol. 175, pp. 105717-105717
Open Access | Times Cited: 2
Therapeutic use of medical Cannabis in neurological diseases: a clinical update
Ute Hidding, Tina Mainka, Carsten Buhmann
Journal of Neural Transmission (2023) Vol. 131, Iss. 2, pp. 117-126
Open Access | Times Cited: 5
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature
Alicia M. Kemble, Benoit Hornsperger, Iris Ruf, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0268590-e0268590
Open Access | Times Cited: 9
Current and emerging pharmacotherapeutic strategies for Tourette syndrome
Andrea E. Cavanna
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 13, pp. 1523-1533
Open Access | Times Cited: 7
Pharmacological Treatment of Tourette Disorder in Children
Afra Can, Jennifer Vermilion, Jonathan W. Mink, et al.
Journal of Child and Adolescent Psychopharmacology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top